Oberto Pharmaceuticals Private Limited
About Oberto Pharmaceuticals Private Limited
Data last updated:
Oberto Pharmaceuticals Private Limited is a private limited company based in Manimajra, Chandigarh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 16 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51909CH2018PTC042039. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Harpreet Kaur and Pushmeet Singh.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Scf 413 2nd Floor Motor Market, Manimajra, Chandigarh, India – 160101.
Company details
Contact details
Oberto Pharmaceuticals Private Limited's registered office is in Manimajra, Chandigarh. Its e-mail address is in the company report.
- Email
- Registered AddressScf 413 2nd Floor Motor Market, Manimajra, Chandigarh, India – 160101
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Oberto Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oberto Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Oberto Pharmaceuticals Private Limited, buy the company report.
Financials of Oberto Pharmaceuticals Private Limited
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Oberto Pharmaceuticals Private Limited, buy the company report.
Board of directors of Oberto Pharmaceuticals Private Limited
Oberto Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harpreet Kaur | Director | 16 Jun 2018 | 8 Years 4 Months | Current |
| Pushmeet Singh Also directs: Bioayur Naturals Private Limited, Shivence Biotech Private Limited | Director | 16 Jun 2018 | 8 Years 4 Months | Current |
Peer comparison
Oberto Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meglife Pharmaceuticals Private Limited | ₹60.21 Lakh (FY 2025) | 3.0% | Chennai, Tamil Nadu, India | |||
| Dewey Pharmaceuticals Private Limited | ₹60.03 Lakh (FY 2024) | 60.0% | Guwahati, Assam, India | |||
| Maclive Pharmaceuticals Private Limited | ₹60.03 Lakh (FY 2025) | 7.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Oberto Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Oberto Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oberto Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oberto Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Oberto Pharmaceuticals Private Limited, buy the company report.
Recent activity
Oberto Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Harpreet Kaur was appointed as Director on 16 Jun 2018.
Frequently asked questions
Oberto Pharmaceuticals is an active private limited company based in Manimajra, Chandigarh, India. The company works in specialty, within the trading industry. It was incorporated on 16 June 2018 (8+ years old) and is registered under CIN U51909CH2018PTC042039.
Oberto Pharmaceuticals has 2 current directors:
- Harpreet Kaur - Director
- Pushmeet Singh - Director
The latest financial statements of Oberto Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2019 are in the company report.
No. Oberto Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Oberto Pharmaceuticals is U51909CH2018PTC042039. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oberto Pharmaceuticals was incorporated on 16 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Oberto Pharmaceuticals by revenue are Meglife Pharmaceuticals Private Limited, Dewey Pharmaceuticals Private Limited, Maclive Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Harpreet Kaur was appointed as Director on 16 Jun 2018. Pushmeet Singh was appointed as Director on 16 Jun 2018.
The registered office of Oberto Pharmaceuticals is at Scf 413 2nd Floor Motor Market, Manimajra, Chandigarh, India – 160101.
Oberto Pharmaceuticals operates in the trading industry, in the specialty segment.
Oberto Pharmaceuticals can be reached at its registered office: Scf 413 2nd Floor Motor Market, Manimajra, Chandigarh, India – 160101.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
